High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients

Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Mar 20, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how high-flow tracheal therapy (HFT) affects the mucus and secretions in patients who have a tracheostomy, which is a procedure that creates an opening in the neck to help with breathing. The main goal is to see if using HFT changes the thickness and stickiness of these secretions compared to when HFT is not used. Additionally, the study will explore how HFT affects patients' breathing comfort and the appearance of their secretions. It will take place at Cliniques Universitaires Saint-Luc and is designed for adult patients who already use HFT at night and need regular suctioning of their trachea.

To participate in this study, individuals must be at least 18 years old and have a tracheostomy. However, those with insufficient secretions for testing or who have cognitive issues will not be eligible. Participants can expect to be part of a randomized crossover study, which means they may experience both the HFT and the standard care during the trial. This research aims to improve the management of secretions in tracheostomized patients and enhance their overall comfort.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥18 years old)
• • Tracheostomized patients
• • Patients requiring routine tracheal suctioning and already using HFT overnight
• Exclusion Criteria:
• • Insufficient secretions for analysis
• • Cognitive impairment or confusion